Abbott Laboratories (ABT) Other Non Operating Income (2009 - 2026)

Abbott Laboratories has disclosed Other Non Operating Income across 18 years of filings, most recently posting $134.0 million for Q2 2026.

• In Q2 2026, Other Non Operating Income fell 2.19% year-over-year to $134.0 million; the TTM figure through Jun 2026 stood at $577.0 million (up 7.05% YoY), while the FY2025 annual figure was -$5.9 billion, up 20.97% from the prior year.
• Other Non Operating Income came in at $134.0 million for Q2 2026 at Abbott Laboratories, down from $159.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $176.0 million in Q2 2023 to a low of -$10.0 million in Q2 2024.
• Average Other Non Operating Income over 5 years is $112.1 million, with a median of $116.0 million recorded in 2023.
• Year-over-year, Other Non Operating Income tumbled 105.68% in 2024 and surged 1470.0% in 2025.
• Over 5 years, Other Non Operating Income stood at $68.0 million in 2022, then surged by 60.29% to $109.0 million in 2023, then surged by 41.28% to $154.0 million in 2024, then retreated by 12.99% to $134.0 million in 2025, then changed by 0.0% to $134.0 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $134.0 million in Q2 2026, $159.0 million in Q1 2026, and $134.0 million in Q4 2025.